A. “More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional),” (RFA-AG-23-021, National Institute on Aging, application deadline Oct. 20, 2022).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-021.html
B. “HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required),” (RFA-DA-23-041, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 27, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional),” (RFA-DA-23-042).
grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-041.html
C. “BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed),” (RFA-EB-22-001, National Institute on Aging, in conjunction with other agencies, application due dates Oct. 13, 2022, Oct. 13, 2023).
grants.nih.gov/grants/guide/rfa-files/RFA-EB-22-001.html
D. “Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed),” (RFA-OD-22-015, National Institute on Aging, in conjunction with other agencies, application due dates Oct. 27, 2022, Oct. 27, 2023).
